Wearable Microneedle Patch Delivers Peptide Drugs Continuously for 24+ Hours Without Electronics | Research

The takeaway

A wearable osmotic microneedle patch maintained stable semaglutide blood levels for 24+ hours in animal models using osmotic pressure — no batteries, pumps, or electronics required.

24+ hour delivery
Wearable microneedle patch maintains stable peptide drug levels using osmotic pressure, eliminating the need for injections

What the researchers found

Osmotic microneedle (OMN) patch achieved sustained drug delivery for ≥24 hours in animal models, maintaining stable plasma concentrations without electronic components.

Why it matters

Peptide drugs like semaglutide and insulin require injections because they cannot be taken orally in most cases. A painless, wearable patch that delivers peptides continuously could transform patient experience and improve drug effectiveness.

The numbers in context

Three hollow microneedles with diameters less than 200 micrometers; sustained drug delivery for at least 24 hours.

How the study worked

Developed osmotic-driven microneedle patch. Characterized drug release kinetics in vitro. Tested sustained drug delivery and plasma pharmacokinetics in animal models.

Who was studied

Animal models receiving sustained drug delivery via osmotic microneedle patch

What this study cannot tell us

Animal study — skin thickness and drug absorption differ in humans. Drug loading capacity for larger peptides needs evaluation. Patch adhesion and comfort over 24 hours in real-world conditions not yet tested in humans.

How to read the evidence

Preliminary evidence: proof-of-concept in animal models with promising drug delivery kinetics, but no human data.

When this study was published

Published in 2024. Addresses a growing need for non-injection peptide delivery.

The bigger picture

The peptide drug delivery market is rapidly growing as more peptide therapeutics are approved. Current delivery is dominated by injections, which limit patient acceptance. Osmotic microneedle patches could make peptide therapy as simple as wearing a bandage, potentially improving adherence for chronic conditions.

Questions still open

Can the OMN patch deliver clinically relevant doses of semaglutide or insulin in humans?
How does patch adhesion and comfort compare to current injection methods over extended wear?
Could this technology enable continuous delivery of peptides that currently require multiple daily injections?

Common questions

How does the microneedle patch work?

Tiny needles on the patch penetrate only the very top layer of skin (painlessly). Osmotic pressure from tissue fluid entering the patch naturally pushes the drug out at a controlled rate, maintaining steady blood levels for 24+ hours — like a self-powered drug pump.

Could this replace weekly semaglutide injections?

Potentially — if the patch can deliver enough drug in humans. A daily or multi-day patch could replace weekly injections for peptide drugs, making treatment more convenient and potentially improving how well the drug works by maintaining steadier blood levels.

Read the original research

A wearable osmotic microneedle patch provides high-capacity sustained drug delivery in animal models.

Science translational medicine, 16(775), eadp3611

View on PubMed ↗Publisher’s paper ↗

Citation

Zhao, Sheng; Lu, Ziyi; Cai, Ruisi; Wang, Hui; Gao, Shukun; Yang, Changwei; Zhang, Ying; Luo, Bowen; Zhang, Wentao; Yang, Yinxian; Wang, Shenqiang; Sheng, Tao; Wang, Shiqi; You, Jiahuan; Zhou, Ruyi; Ji, Huimin; Gong, Haoning; Ye, Xiao; Yu, Jicheng; Zhu, Hong-Hu; Zhang, Yuqi; Gu, Zhen. (2024). A wearable osmotic microneedle patch provides high-capacity sustained drug delivery in animal models.. Science translational medicine, 16(775), eadp3611. https://doi.org/10.1126/scitranslmed.adp3611